Literature DB >> 8240510

Clozapine in the management of schizophrenia. Clozapine has unique pharmacological profile.

S M Dursun, M A Reveley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8240510      PMCID： PMC1678356          DOI： 10.1136/bmj.307.6897.200

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Clozapine: progress in treating refractory schizophrenia.

Authors:  S R Hirsch; B K Puri
Journal:  BMJ       Date:  1993-05-29

2.  Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol.

Authors:  M Kuoppamäki; T Seppälä; E Syvälahti; J Hietala
Journal:  J Pharmacol Exp Ther       Date:  1993-03       Impact factor: 4.030

3.  Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors.

Authors:  B L Roth; R D Ciaranello; H Y Meltzer
Journal:  J Pharmacol Exp Ther       Date:  1992-03       Impact factor: 4.030
  3 in total
  2 in total

1.  Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study.

Authors:  S M Dursun; A Szemis; H Andrews; P Whitaker; M A Reveley
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

2.  Neuroanatomical, neurochemical, and neurodevelopmental basis of obsessive-compulsive symptoms in schizophrenia.

Authors:  Ganesan Venkatasubramanian; Naren P Rao; Rishikesh V Behere
Journal:  Indian J Psychol Med       Date:  2009-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.